On our screens:Cheap stocks by free cash flow yield
Is the price fair?
What GMED's price assumes
Globus Medical, Inc. trades at 17.5× earnings against 30.9× for the median Medical Devices name, cheaper than its own group.
17.5
Trailing P/E · Medical Devices median 30.9 · cheaper than the typical name in its group
- Price / sales
- 3.84
Price / sales · as of 2026-Q1
- Free cash flow yield
- 5.3%
Free cash flow yield · Medical Devices median 3.9%
- Growth the price implies
- +4.9%
Growth the price implies · The price pays for +4.9% free cash flow growth a year for a decade; the business has delivered +73% a year over the last three.
Details›
- Price / book2026-Q1
- 2.52
- Healthcare median P/E362 names
- 29.9
- Medical Devices median P/E39 names
- 30.9
- Free cash flow, trailing twelve months
- $610M
- Market capitalisation
- $11.5B
- 3-year revenue growth
- +43%
- 3-year free cash flow growth
- +73%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $142.49 |
| Its own P/E history, median | $167.93 |
| Its own P/E history, upper quartile | $217.12 |
| 52-week range | $55.10 – $96.82 |
| Today | $75.04 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Devices
Ranks #1 of 29 by Smart Score